Why the study?
Does anti-minK antisense decrease the amplitude of the rapidly activating cardiac delayed rectifier K+ current in atrial tumor myocytes?
Population
Atrial tumor myocytes (AT-1 cells)
Comparison
Antisense oligonucleotides targeting the 5′… vs Corresponding sense oligonucleotide, random…
Design
Preclinical
Follow-up
24 to 48 hours
Authors
Loading...
minK knockdown reduces IKr in atrial myocytes; leaves open its role in human arrhythmias or antiarrhythmic targeting.
Does anti-minK antisense decrease the amplitude of the rapidly activating cardiac delayed rectifier K+ current in atrial tumor myocytes?
Antisense knockdown of minK in AT-1 cells significantly reduces IKr amplitude without affecting channel kinetics or calcium currents, indicating minK plays a role in determining IKr amplitude.
Yang et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: